# FMC Corp: Form 10-Q for the period ended Mar 31, 2009

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2009-05-08
- Accepted by EDGAR: May 8, 2009, 15:30 ET
- Period: 2009-03-31
- Accession: 0001193125-09-104841
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000119312509104841/d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000119312509104841/

## Management's discussion and analysis

As filed, 55,543 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2008 (the “2008 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part 1 of the 2008 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2008 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed with the Audit Committee of our Board of Directors those accounting policies that we have deemed critical. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2008 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting standards and other new accounting standards.

### OVERVIEW

We are a diversified, global chemical company providing innovative solutions, applications and market leading products to a wide variety of markets. We operate in three distinct business segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals. Our Agricultural Products segment primarily focuses on insecticides and herbicides, which are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects and weeds as well as pest control in non-agricultural markets. Specialty Chemicals consists of our BioPolymer and lithium businesses and focuses on food ingredients that are used to enhance texture, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications, ultrapure biopolymers for medical devices and lithium specialties for pharmaceutical synthesis, specialty polymers and energy storage. Our Industrial Chemicals segment manufactures a wide range of inorganic materials, including soda ash, hydrogen peroxide, specialty peroxygens and phosphorus chemicals.

### First Quarter 2009 Highlights

Our consolidated revenue of $690.5 million decreased eight percent compared to the first quarter of 2008. Agricultural Products, Specialty Chemicals and Industrial Chemicals had revenue decreases of six percent, five percent and 12 percent, respectively. Agricultural Products operating profit increased 12 percent while Specialty Chemicals and Industrial Chemicals operating profits decreased four percent and 36 percent, respectively compared to the prior year period. Our segment results for the three months ended March 31, 2009 were impacted by the following:

- Agricultural Products’ Segment operating profit increased as a result of stronger performance in North America and Europe coupled with favorable product and geographical mix, partially offset by lower performance in Brazil.
- Specialty Chemicals’ Segment operating profit decreased as a result of lower lithium volumes, which more than offset the strong commercial performance and favorable mix in BioPolymer.
- Industrial Chemicals’ Segment operating profit decreased as lower volumes and higher raw material and energy costs more than offset higher selling prices across the segment.

Included in our net income were various restructuring and other income and charges which are described in more detail below under “Results of operations”. There was a significant increase in restructuring and other income and charges due to the Santa Clara and Bayport butyllithium facility shutdowns as well as the Alginates manufacturing realignment described below as well as the absence of prior year gains related to the Princeton and Foret asset sales.

On February 20, 2009, we acquired the CB Professional Products line of insect control products from Waterbury Companies, Inc. This acquisition is being integrated into our Agricultural Products Group. This acquisition fits with our strategic goal of offering a broad product portfolio to pest control distribution and a comprehensive set of solutions to pest management professionals.

In March 2009, we made the decision to shut down our manufacturing operations at our Peroxygens facility in Santa Clara, Mexico, which is part of our Industrial Chemicals segment. The decision to shut down the Santa Clara operations was made in an effort to maximize cost savings and improve efficiencies.

In March 2009, we made the decision to close our Bayport butyllithium facility located in Bayport, Texas. The Bayport butyllithium facility is part of our Lithium division which is included in our Specialty Chemicals segment. Our decision is consistent with our ongoing strategy to be globally competitive and focus on products consistent with market demands.

In January 2009, we announced plans to realign our BioPolymer alginates manufacturing operations in Norway and the United Kingdom as the company continues integration of the International Specialty Products (ISP) alginates business acquired in August 2008.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*(in Millions)*

| Revenue | Three Months Ended March 31, 2009 | 2008 |
| --- | ---: | ---: |
| Agricultural Products | $261.4 | $277.5 |
| Specialty Chemicals | 174.6 | 183.7 |
| Industrial Chemicals | 256.0 | 290.4 |
| Eliminations | (1.5) | (1.4) |
| Total | $690.5 | $750.2 |
| **Income (loss) from continuing operations before income taxes** |  |  |
| Agricultural Products | $92.5 | $82.9 |
| Specialty Chemicals | 38.1 | 39.5 |
| Industrial Chemicals | 22.8 | 35.6 |
| Eliminations | (0.2) | (0.2) |
| **Segment operating profit (1)** | 153.2 | 157.8 |
| Corporate | (11.3) | (11.9) |
| Other income (expense), net | (3.6) | (3.0) |
| Interest expense, net | (7.0) | (8.7) |
| Corporate special income (charges): |  |  |
| Restructuring and other income (charges) | (22.5) | 8.3 |
| Purchase accounting inventory fair value impact | (1.9) | — |
| Provision for income taxes | (33.4) | (42.2) |
| Discontinued operations, net of income taxes | (4.4) | (6.4) |
| **Net income attributable to FMC stockholders** | $69.1 | $93.9 |

(1) Results for all segments are net of noncontrolling interests of $1.8 million and $2.9 million in the three months ended March 31, 2009 and 2008, respectively, the majority of which pertains to Industrial Chemicals.

The below chart, which is provided to assist readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows.

| Net income includes the following after-tax charges (gains): | Three Months Ended March 31, 2009 | 2008 |
| --- | ---: | ---: |
| Corporate special charges (income) | 16.7 | (9.1) |
| Discontinued operations | 4.4 | 6.4 |
| Tax adjustments | (0.9) | — |

30

### Three months ended March 31, 2009 compared to Three months ended March 31, 2008

In the discussion below, please refer to our chart on page 30 under “Overview”. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges, investment gains and losses, loss on extinguishment of debt, asset impairments, LIFO inventory adjustments, amortization of inventory step-up from business acquisitions, and other income and expense items.

Information about how each of these items relate to our businesses at the segment level is discussed in Note 20 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our 2008 consolidated financial statements in our 2008 10-K.

### Agricultural Products

*(in Millions)*

|  | Three Months Ended March 31, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $261.4 | $277.5 | $(16.1) | (6)% |
| Operating Profit | 92.5 | 82.9 | 9.6 | 12 |

Sales of $261.4 million decreased approximately six percent versus the prior year quarter, as lower sales in Latin America, primarily Brazil, and Asia more than offset sales gains in North America and Europe. Latin America sales declined approximately 26 percent primarily due to lower planted acres in cotton and reduced volumes to the sugar cane market driven by unfavorable market conditions, including the lack of readily available financing for many sugar mills. Sales in Asia declined three percent, as a result of lower sales in Australia compared with particularly strong demand a year ago. North America crop sales increased by 25 percent driven primarily by growth from new product introductions and strong early season herbicide demand. Europe sales increased nine percent driven by higher selling prices and the timing of sales, offset by unfavorable currency impacts.

Agricultural Products’ operating profit of $92.5 million was approximately 12 percent higher than the year-ago quarter, reflecting stronger sales performance in North America and Europe coupled with favorable product and geographic mix, partially offset by lower performance in Brazil.

In 2009, full-year revenue growth in the mid-single digits is expected, driven by growth in the Americas and Europe partially offset by unfavorable currency impacts. Full-year segment operating profit is expected to be up in the low-to-mid teens, as higher selling prices, favorable product and geographic mix, new product introductions and lower raw material costs are partially offset by spending on growth initiatives.

In our Agricultural Products segment, several products are undergoing re-registration in the U.S. and/or a comparable regulatory review by the European Union (“EU”) governmental authorities. In August 2006, the U.S. Environmental Protection Agency issued its “Interim Reregistration Eligibility Decision” (“IRED”) for our carbofuran insecticide. The IRED proposes cancellation of all carbofuran uses in the United States, subject to a phase out period for certain minor crop uses while maintaining tolerances for imported commodities (bananas, coffee, rice and sugarcane). The EPA reiterated its proposal in January 2008 with the issuance of a draft Notice of Intent to Cancel. In February 2008, the EPA convened a Scientific Advisory Panel meeting to evaluate scientific issues relevant to the draft Notice of Intent to Cancel carbofuran. At this meeting, the EPA and FMC presented their views on the relevant scientific assessments of carbofuran. Separately, the U.S. Department of Agriculture issued its comments on the draft cancellation notice, stating that carbofuran should continue to be registered. On July 24, 2008, the EPA published a proposal to revoke all carbofuran tolerances under the Federal Food Drug and Cosmetic Act in advance of any issuance of a final Notice of Intent to Cancel under the federal pesticide law. We have responded to that notice, expressing our strong disagreement with the EPA’s proposal to revoke tolerances and our belief that carbofuran residues on food do not pose a threat to human health. If the EPA chooses to revoke tolerances or issue a final Notice of Intent to Cancel which continues to eliminate all carbofuran uses, FMC plans to challenge such decision by requesting review by an administrative law judge. Meanwhile, FMC can continue to sell carbofuran in the United States at this time. Should the EPA issue a final decision to revoke tolerances, the EPA will also decide on when the revocation will take effect. If tolerances are revoked immediately and we cannot obtain a stay of such decision, sales of carbofuran into the relevant crops will be negatively impacted. We expect a final EPA decision on the tolerance revocation proposal in the first half of 2009. The conclusion of any subsequent administrative hearing(s) might take as long as a year from the issuance of a final revocation order. We do not know the EPA’s timing on a final Notice of Intent to Cancel the carbofuran registration, though the EPA has said it intends to issue such notice after the tolerance revocation decision.

In November 2006, the EU Commission’s Standing Committee on Animal Health and Food Chain voted not to include our carbofuran, carbosulfan and cadusafos products on the official list of active ingredients approved for continued sale in the EU. We believe the Committee’s decision was based on a flawed underlying scientific review and a failure to take into account all available data. In June 2007, the European Commission published its decisions not to include carbofuran, carbosulfan and cadusafos on the official list of active ingredients approved for continued sale in the EU. The published decisions required EU Member States to de-register the products within six months, and so FMC ceased its sales of these products in December 2007. We disagreed with the Commission and initiated litigation in the European Community courts, seeking annulment of the carbofuran and carbosulfan decisions; in February 2009, we withdrew those cases. We have also re-submitted cadusafos, carbofuran and carbosulfan for approval on the official list. The outcome of our regulatory resubmissions is uncertain.

Also in the EU, two of our pyrethroid insecticide products, bifenthrin and zeta-cypermethrin, were considered this year for inclusion on the official list of EU-approved active ingredients. In January 2009, we were informed that the Standing Committee voted in favor of including zeta-cypermethrin on the official list. In March 2009 the Commission proposed not to include bifenthrin on the official list, but the Standing Committee rejected that proposal. The regulatory decision has now been referred to the EU Council of Ministers. The outcome of the Council’s decision is uncertain. We expect to have a final decision regarding bifenthrin by the end of 2009. In the interim, sales of bifenthrin will continue throughout 2009. If bifenthrin is not included on the official list, we intend to re-submit immediately for reconsideration and thereby seek to minimize any interruption in sales.

We intend to defend vigorously all our products in the U.S., EU and other countries’ regulatory processes where FMC’s pesticide products will be reviewed in the ordinary course of regulatory programs during 2009 as part of the ongoing cycle of re-registration in countries around the world.

### Specialty Chemicals

*(in Millions)*

|  | Three Months Ended March 31, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $174.6 | $183.7 | $(9.1) | (5)% |
| Operating Profit | 38.1 | 39.5 | (1.4) | (4) |

Revenue in Specialty Chemicals was $174.6 million, a decrease of approximately five percent versus the prior-year quarter. BioPolymer sales increased seven percent on higher selling prices as well as the contribution of the alginates and food ingredients acquisitions. This was more than offset by lithium’s sales decline of 32 percent on lower volumes across the business due to significantly weaker demand and inventory destocking along the supply chain for primary compounds and butyllithium. The industrial, energy storage and polymer markets were particularly affected. Pricing across the business remained stable.

Segment operating profit of $38.1 million decreased four percent versus the year ago quarter, primarily as a result of lower lithium volumes, which more than offset the strong commercial performance and favorable mix in BioPolymer. In BioPolymer, earnings improved on revenue growth, favorable product mix and continued productivity improvements partially offset by higher raw material and energy costs. In lithium, earnings declined with the fall in volumes.

In 2009, full-year revenue growth in the low single digits is expected, as higher volumes and improved pricing in BioPolymer is largely offset by lower lithium volumes. Full-year segment operating profit is expected to be up in the mid-single digits driven by strong BioPolymer results partially offset by lower lithium performance.

### Industrial Chemicals

*(in Millions)*

|  | Three Months Ended March 31, 2009 | 2008 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $256.0 | $290.4 | $(34.4) | (12)% |
| Operating Profit | 22.8 | 35.6 | (12.8) | (36) |

Revenue in Industrial Chemicals was $256.0 million, a decrease of approximately 12 percent versus the prior-year quarter. Volume declines across the segment reduced revenues by 21 percent which was partially offset by a 14 percent increase in pricing. Unfavorable currency translation further reduced revenues by three percent. In soda ash, both domestic and export selling prices benefited from higher 2009 contract levels while volumes were down relative to a year ago, particularly in the export markets. Across all regions, the flat glass market was most affected by the downturn. Our North American Peroxygens business realized higher selling prices in both our hydrogen peroxide and specialty peroxygens businesses. Volumes declined primarily as a result of soft pulp and paper, polymer and oilfield services markets. Foret also realized higher selling prices across its entire product line. As in North America, hydrogen peroxide volumes in Europe declined as a result of softer pulp and paper market conditions. In phosphates, reduced volumes were primarily driven by lower phosphate based detergent demand due to generic substitution and product reformulations.

Segment operating profit of $22.8 million decreased approximately 36 percent versus the year ago quarter as lower volumes and higher raw material costs, particularly for phosphate rock, of $18.5 million, and energy costs more than offset higher selling prices.

In 2009, full-year revenue is expected to be down 10 – 15 percent as higher selling prices across most businesses are more than offset by lower volumes and unfavorable currency translation. Full-year segment operating profit is expected to be down 20—30 percent as higher selling prices are more than offset by volume declines and higher raw material and energy costs.

### Other Results of Operations

#### Corporate Expenses

We recorded charges of $11.3 million in first quarter of 2009 compared to $11.9 million in the first quarter of 2008. This decrease was primarily due to reduced incentive compensation expense in the first quarter of 2009 compared to the same period in 2008. Corporate expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Other income (expense), net

Other income (expense), net is comprised primarily of LIFO inventory adjustments and pension expense. Other expense increased to $3.6 million in the first quarter of 2009 from $3.0 million in the same period of 2008. The increase was due primarily to higher charges related to our LIFO inventory reserves and higher pension expense. These charges were partially offset by the mark to market impact of our deferred compensation liability and a gain from a foreign exchange transaction.

#### Interest expense, net

Interest expense, net for the first quarter of 2009 was $7.0 million as compared to $8.7 million in the first quarter of 2008. The decrease was due to lower interest rates on the borrowings under our credit agreements as compared to the prior period.

#### Corporate special income (charges)

*Restructuring and other charges (income)* totaled $22.5 million in the first quarter of 2009. Charges (income) in this category for the quarter ended March 31, 2009 include the following:

- A $6.5 million charge in our Industrial Chemicals segment due to our decision to shut down our manufacturing operations at our Peroxygens facility in Santa Clara, Mexico. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of approximately $3.3 million, (ii) severance and employee benefits of $1.5 million and (iii) other shut down costs of approximately $1.7 million.
- A $4.1 million charge in our Specialty Chemicals segment due to our decision to close our Bayport butyllithium facility located in Bayport, Texas. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of approximately $3.4 million, and (ii) severance and employee benefits of $0.7 million.
- A $2.8 million charge in our Specialty Chemicals segment due to the realignment of our BioPolymer alginates manufacturing operations. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of approximately $1.3 million, and (ii) severance and employee benefits of $1.5 million.
- A $1.0 million charge related to our Agricultural Products segment acquiring further rights under a collaboration and license agreement with a third-party company.
- A $0.8 million charge in our Agricultural Products segment due to our decision to phase-out operations at our Baltimore, Maryland agricultural chemicals facility. The charge consisted primarily of demolition costs. We ceased production at this facility in the second quarter of 2008.
- $1.5 million of severance costs due to workforce restructurings, primarily related to our Industrial Chemicals segment
- Asset abandonment charges of $3.9 million, of which $2.5 million related to our Agricultural Products segment and $1.4 million related to our Industrial Chemicals segment.
- $1.2 million relating to continuing environmental sites as a Corporate charge.
- $0.7 million of other charges primarily in our Industrial Chemicals segment which represent the accrual of interest associated with the European Commission fine.

Restructuring and other charges (income) totaled a net gain of $8.3 million in the first quarter of 2008 primarily as a result of a $29.6 million gain related to the sale of the Princeton property and a gain of $3.6 million related to the sale of Foret’s sodium sulfate assets. Foret is part of our Industrial Chemicals segment. These gains were partially offset by restructuring charges of $15.8 million related to the phase-out of the Agricultural Products chemical facility in Baltimore, Maryland in our Agricultural Products segment. Remaining charges in the first quarter of 2008 primarily included $3.2 million of severance costs due to workforce restructurings, of which $1.9 million related to our Agricultural Products segment, $1.1 million related to our Industrial Chemicals segment and $0.2 million related to our Specialty Chemicals segment. Additionally, charges of $5.9 million were incurred primarily consisting of $4.9 million of charges related to continuing environmental sites which is a Corporate charge and $1.0 million of other charges primarily related to our Industrial Chemicals segment.

*Purchase accounting inventory fair value impact* represents $1.9 million in charges related to amortization of the inventory fair value step-up resulting from the application of purchase accounting associated with the third quarter 2008 acquisition in our Specialty Chemicals segment and the first quarter 2009 acquisition in our Agricultural Products segment. On the condensed consolidated statements of income these charges are included in “Costs of sales and services” for the three months ended March 31, 2009.

#### Provision for income taxes

We recorded a provision of $33.4 million for the first quarter of 2009 compared to a provision of $42.2 million for the prior period resulting in effective tax rates of 30.7 percent and 29.0 percent, respectively. The increase in the effective tax rate was primarily a result of a change in the mix of domestic income compared to income earned outside of the U.S. Income we earn domestically is typically taxed at rates higher than income earned outside the U.S. The effective tax rate was also favorably impacted by tax adjustments recorded during the three months ended March 31, 2009, primarily related to reductions to our tax liabilities related to prior year tax matters.

#### Discontinued operations, net of income taxes

Discontinued operations, net of income taxes totaled a loss of $4.4 million for the three months ended March 31, 2009 compared to loss of $6.4 million for the three months ended March 31, 2008. The losses recorded for the quarters ended March 31, 2009 and 2008 are primarily related to environmental charges to increase our reserve for operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders decreased to $69.1 million for the three months ended March 31, 2009 from $93.9 million for the three months ended March 31, 2008. The decrease was primarily due to lower Industrial Chemicals segment operating profit and significantly higher restructuring and other charges (income). Partially offsetting this was higher profits in our Agricultural Products segment and a reduction in interest expense.

### LIQUIDITY AND CAPITAL RESOURCES

#### Domestic Credit Agreement

On August 28, 2007, we executed a new credit agreement (the “Domestic Credit Agreement”) which provided for a five-year, $600 million revolving credit facility. The proceeds from this facility are available for general corporate purposes, including issuing letters of credit up to a $300 million sub-limit. The Domestic Credit Agreement also contains an option under which, subject to certain conditions, we may request an increase in the facility to $1 billion.

There were no borrowings under the new facility at inception, and our prior credit agreement dated as of June 21, 2005 was terminated. Obligations under the prior credit agreement and related transaction costs, fees, and expenses for the new Agreement were paid with available cash. Loans under the facility bear interest at a floating rate, either a base rate as defined or the applicable euro currency rate for the relevant term plus an applicable margin. At March 31, 2009, the applicable euro currency margin was 0.35 percent, subject to adjustment based on the credit rating assigned to our senior unsecured debt. At March 31, 2009, borrowing rates under our Domestic Credit Agreement ranged from 0.69 to 3.25 percent per annum.

#### European Credit Agreement

On December 16, 2005, our Dutch finance subsidiary executed a credit agreement (the “European Credit Agreement”) which provides for an unsecured revolving credit facility in the amount of €220 million. Borrowings may be denominated in euros or U.S. dollars. FMC and our Dutch finance subsidiary’s direct parent provide guarantees of amounts due under the European Credit Agreement.

Loans under the European Credit Agreement bear interest at a euro currency base rate, which for loans denominated in euros is the Euro InterBank Offered Rate, and for loans denominated in dollars is London Interbank Offered Rate (“LIBOR”) in each case plus a margin. The applicable margin under our European Credit Agreement is subject to adjustment based on the credit rating assigned to our senior unsecured debt. At March 31, 2009, the applicable margin was 0.35 percent and the applicable borrowing rate under the European Credit Agreement ranged from 1.51 to 3.41 percent per annum.

Among other restrictions, the Domestic Credit Agreement and the European Credit Agreement contain financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended March 31, 2009 was 1.2 which is within the maximum leverage 3.5. Our actual interest coverage for the four consecutive quarters ended March 31, 2009 was 19.9 which is within the minimum interest coverage of 3.5. We were in compliance with all covenants at March 31, 2009.

At March 31, 2009, we had $129.0 million in U.S. dollar equivalent revolving credit facility borrowings under the European Credit Agreement compared to $157.2 million at December 31, 2008. Available funds under this facility were $163.6 million and $150.2 million at March 31, 2009 and December 31, 2008, respectively.

We had $244.0 million of borrowings under our Domestic Credit Agreement at March 31, 2009 compared to $203.0 million of borrowings at December 31, 2008. Letters of credit outstanding under the Domestic Credit Agreement totaled $149.6 million and $151.5 million at March 31, 2009 and December 31, 2008, respectively. As such, available funds under the Domestic Credit Agreement were $206.4 million and $245.5 million at March 31, 2009 and December 31, 2008, respectively.

Cash and cash equivalents at March 31, 2009 and December 31, 2008 were $54.9 million and $52.4 million, respectively. At March 31, 2009, we had total debt of $668.2 million as compared to $623.6 million at December 31, 2008. This included $617.8 million and $592.9 million of long-term debt (excluding current portions of $1.9 million and $2.1 million) at March 31, 2009 and December 31, 2008, respectively. Short-term debt, which consists solely of foreign borrowings, increased to $48.5 million at March 31, 2009 compared to $28.6 million at December 31, 2008.

#### Statement of Cash Flows

Cash provided by operating activities was $24.8 million for three months ended March 31, 2009 compared to cash required by operating activities of $54.5 million for the three months ended March 31, 2008. The increase in cash provided by operating activities in 2009 compared to 2008 reflects our change in business conditions. Net income attributable to FMC stockholders declined by approximately $25 million. While business conditions did deteriorate in the first quarter of 2009 and revenues declined, our earnings remained relatively stable when excluding restructuring and other charges (income) which were favorably impacted in 2008 by the gain on sales of our research and development facility in Princeton and our sodium sulfate assets in Foret. The effects of the change in business conditions had a greater impact on working capital. Lower revenues versus last year’s first quarter led to a significant reduction in our receivables. Despite the significant deterioration in the global economy our receivables experience, both in terms of collections and on-time payments, has shown little deterioration period over period. Inventories increased as a result of the sales slowing more quickly than was anticipated. Accounts payable decreased as we settled inventories purchased in the later part of 2008 and reduce future investments in inventories as we begin to work down current inventory levels.

Cash required by operating activities of discontinued operations was $9.6 million for the first three months of 2009 compared to cash required of $11.9 million for the first three months of 2008. This change was primarily due to decreased environmental spending as well as lower spending for legal proceedings associated with discontinued operations in the three months ended March 31, 2009.

Cash required by investing activities was $44.4 million for the three months ended March 31, 2009 compared to cash provided of $44.6 million for the three months ended March 31, 2008. The change was driven primarily by acquisitions in 2009 and the absence of proceeds from the sale of the properties and assets during the three months ended March 31, 2009 as compared to the same period in 2008.

Cash provided by financing activities was $32.1 million for the first three months of 2009 compared to cash provided of $16.5 million for the first three months of 2008. This change is due primarily to an increase in our short-term debt, a reduction in repurchases of stock as we did not purchase any additional shares under our publicly announced repurchase program during the first quarter of 2009, partially offset by higher repayments of long-term debt.

### Other potential liquidity needs

Our cash needs for 2009 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, contributions to our pension plans, environmental spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations and borrowings under our committed revolving credit facilities. We continually evaluate our options for divesting real estate holdings and property, plant and equipment that are no longer integral to any of our core operating businesses.

Projected 2009 capital expenditures are expected to be in line with 2008 levels.

Projected 2009 spending includes approximately $31.2 million of net environmental remediation spending. This spending does not include expected spending of approximately $15.4 million in 2009 on capital projects relating to environmental control facilities. Also, we expect to spend approximately $24.5 million in 2009 for environmental compliance costs, which we will include as a component of costs of sales and services in our consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls above the foregoing projections.

During 2008, the world equity markets were down significantly, exemplified by the S&P 500 index in the U.S. being down 37 percent. Our U.S. qualified defined benefit pension plan (“U.S. Plan”) assets fell from $829.4 million at December 31, 2007 to $563.9 million at December 31, 2008. Our U.S. Plan assets comprise approximately 93 percent of our total plan assets with the difference representing plan assets related to foreign pension plans. We have reduced our expected return on our U.S. Plan assets from 8.75 percent in 2008 to 8.5 percent in 2009. In developing the assumption for the long-term rate of return on assets for our U.S. Plan, we take into consideration the technical analysis performed by our outside actuaries, including historical market returns, information on the assumption for long-term real returns by asset class, inflation assumptions, and expectations for standard deviation related to these best estimates. We also consider the historical performance of our own plan’s trust, which has earned a compound annual rate of return of approximately 9.51 percent over the last 20 years (which is in excess of comparable market indices for the same period) as well as other factors. Given an actively managed investment portfolio, the expected annual rates of return by asset class for our portfolio, using geometric averaging, and after being adjusted for an estimated inflation rate of approximately 2.75 percent, is between 8.75 percent and 10.75 percent for equities, and between 4.25 percent and 7.75 percent for fixed-income investments, which generates a total expected portfolio return that is in line with our assumptions for the rate of return on assets. This lower expected return on plan assets, along with decreased assets and the amortization of actuarial losses primarily associated with the equity market decline in 2008 are estimated to increase our net periodic benefit costs by approximately $5.7 million during 2009 compared to 2008. Under The Pension Protection Act of 2006, we are not required to make a minimum level of funding into the U.S. Plan during 2009, however, in order to reduce future funding volatility we intend to contribute $75 million in 2009 versus $30 million contributed in 2008 and 2007. We do not believe that the additional contribution will have a significant negative impact on our current and future liquidity needs. However a continuation of the volatility of interest rates and negative equity returns under current market conditions may require greater contributions to the Plan in the future. We did not make any of the voluntary contributions to the plan during the three months ended March 31, 2009.

On April 16, 2009, we paid dividends aggregating $9.1 million to our shareholders of record as of March 31, 2009. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheets as of March 31, 2009. For the three months ended March 31, 2009 and 2008, we paid $9.1 million and $7.9 million in dividends, respectively.

In April 2007, the Board of Directors authorized the repurchase of up to $250 million of our common stock. In October 2008, the Board authorized the repurchase of up to an additional $250 million of our common stock. Although the repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time, we expect that the program will be accomplished over a two-year period. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time in connection with the vesting and exercise of awards under our equity compensation plans. During the three months ended March 31, 2009, we did not repurchase any of our shares under the publicly announced repurchase program.

### Commitments

In 2001, we split FMC into separate chemical and machinery companies and we refer to the spun-off company, FMC Technologies, Inc. as “Technologies” throughout this Quarterly Report. We agreed to guarantee the performance by Technologies of a debt instrument (see Note 19 to the condensed consolidated financial statements in this Form 10-Q). These guaranteed obligations totaled $0.8 million as of March 31, 2009 and December 31, 2008.

We also guarantee repayment of some of the borrowings of certain foreign affiliates accounted for using the equity method for investments. The other equity investors provide parallel agreements. In addition, we guarantee the repayment of the borrowing of a minority partner in a foreign affiliate that we consolidate in our financial statements. As of March 31, 2009 these guarantees had maximum potential payments of $7.6 million as compared to $6.8 million as of December 31, 2008.

We provide guarantees to financial institutions on behalf of certain Agricultural Products customers, principally in Brazil, for their seasonal borrowing. The total of these guarantees was $23.7 million and $20.3 million at March 31, 2009 and December 31, 2008, respectively, and are recorded on the condensed consolidated balance sheets for each date as “Guarantees of vendor financing”.

Short-term debt consisted of foreign credit lines at March 31, 2009 and December 31, 2008. We provide parent-company guarantees to lending institutions providing credit to our foreign subsidiaries.

In connection with our property and asset sales and divestitures, we have agreed to indemnify the buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale. Our indemnification obligations with respect to these liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum claim amount or cap. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover certain of the indemnity payments from third parties. We have not recorded any specific liabilities for these guarantees.

We spun off FMC Technologies, Inc. (“Technologies”) in 2001. At this time, we entered into a tax sharing agreement wherein each company is obligated for those taxes associated with its respective business, generally determined as if each company filed its own consolidated, combined or unitary tax returns for any period where Technologies is included in the consolidated, combined or unitary tax return of us or our subsidiaries. The statute of limitations for the 2001 U.S. federal income tax year has now closed and no questions regarding the spin-off were raised during the IRS audit for 2000-2001, therefore any liability for taxes if the spin-off of Technologies were not tax free due to an action taken by Technologies has been favorably concluded. The tax sharing agreement continues to be in force with respect to certain items, which we do not believe would have a material effect on our financial condition or results of operations.

### Contingencies

On January 28, 2005, we and our wholly owned subsidiary Foret received a Statement of Objections from the European Commission concerning alleged violations of competition law in the hydrogen peroxide business in Europe during the period 1994 to 2001. All of the significant European hydrogen peroxide producers also received the Statement of Objections. We and Foret responded to the Statement of Objections in April 2005 and a hearing on the matter was held at the end of June 2005. On May 3, 2006, we received a notice from the European Commission indicating that the Commission had imposed a fine on us and Foret in the aggregate amount of €25.0 million as a result of alleged violations during the period 1997-1999. In connection with this fine, we recorded an expense of $30.0 million (reflecting then-prevailing exchange rates) in our consolidated statements of income for the year ended December 31, 2006. This expense was included as a component of restructuring and other charges (income). Since we are not required to make the payment during the appeal process, which may extend beyond one year, the liability has been classified as long-term in the condensed consolidated balance sheets as of March 31. 2009 and December 31, 2008. Both we and Foret have appealed the decision of the Commission. During the appeal process, interest accrues on the fine at a rate, which as of March 31, 2009, was 4.0 percent per annum. We have provided a bank letter of credit in favor of the European Commission to guarantee our payment of the fine and accrued interest. At March 31, 2009, the amount of the letter of credit was €28.2 million (U.S. $37.5 million).

In 2004, we also received a subpoena for documents from a grand jury sitting in the Northern District of California, which was investigating anticompetitive conduct in the hydrogen peroxide business in the United States during the period 1994 through 2003. We have since learned that Degussa AG was a leniency applicant in the investigation and that Solvay, S.A. and Akzo Nobel Chemicals International B.V. have pled guilty to Sherman Act violations during the period July 1, 1998 through December 1, 2001. On December 29, 2008, we received notice from the Department of Justice that it has closed the investigation without filing charges against FMC.

In connection with these two matters, in February 2005 putative class action complaints were filed against six U.S. hydrogen peroxide producers (and certain of their foreign affiliates) in various federal courts alleging violations of antitrust laws. Federal law provides that persons who have been injured by violations of federal antitrust law may recover three times their actual damage plus attorney fees. Related cases were also filed in various state courts. All of the federal court cases were consolidated in the United States District Court for the Eastern District of Pennsylvania (Philadelphia). The District Court certified the class in January 2007. On December 30, 2008, the Court of Appeals vacated the class certification order and remanded the case for further proceedings in the District Court. Shortly thereafter, FMC reached an agreement to settle with the class for $10 million, with a pro rata credit for opt outs. This settlement has been preliminarily approved by the Court. The Court has also preliminarily approved a settlement with Arkema and finally approved settlements with four of the six original defendant-groups, who collectively paid approximately $90 million. Seventeen companies (predominantly paper producers) have opted out of certain of the settlements with other defendants. Certain of the defendants in the class action have settled those opt out claims for undisclosed amounts. Several opt outs have filed suit against FMC and, in some cases, Foret. These cases have been assigned to the same judge as the class action, and the stay of these actions entered by the District Court during the class certification appeal remains in place. Most of the state court cases have been dismissed, although some remain in California. In addition, putative class actions against the six major hydrogen peroxide producers have been filed in provincial courts in Ontario, Quebec and British Columbia under the laws of Canada. A motion for class certification is pending. Four of the defendants have settled these claims for a total of approximately $20.5 million. FMC intends to defend these cases.

On January 19, 2009, the European Commission decided to initiate proceedings against FMC, its Netherlands subsidiary, and Foret, following an investigation of substantially all of the European producers of animal feed phosphates, with respect to alleged anti-competitive activity in the industry during the period 1989-2003. Simultaneously with giving notice of this decision, the Commission invited FMC and its subsidiaries to engage in settlement discussions under a new Commission program designed to resolve such matters without the need for the full official process. We have agreed to explore participation in this program and are in the process of meeting with the Commission to discuss the matter. We understand that the other producers have received similar communications, and that some of them have in fact already reached confidential settlements.

We have certain other contingent liabilities arising from litigation, claims, performance guarantees and other commitments incident to the ordinary course of business. Based on information currently available and established reserves the ultimate resolution of our known contingencies, including the matters described in Note 19 to our condensed consolidated financial statements included in this Form 10-Q, is not expected to have a material adverse effect on our consolidated financial position or liquidity. However, there can be no assurance that the outcome of these contingencies will be favorable, and adverse results in certain of these contingencies could have a material adverse effect on our consolidated financial position, results of operations or liquidity.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen. We calculate the market value foreign currency risk using third-party software incorporating standard pricing models to determine the present value of the instruments based on market conditions (spot and forward foreign exchange rates) as of the valuation date. We obtain estimates of the market value energy price risk from calculations performed internally and by a third party.

At March 31, 2009, our net financial instrument position was a net liability of $33.9 million compared to a net liability of $39.9 million at December 31, 2008. The change in the net financial instrument position was due to lower unrealized losses in our foreign exchange portfolio partially offset by higher unrealized losses in our commodity portfolio.

### Commodity Price Risk

Energy costs are approximately 13 percent of our cost of sales and services and are well balanced among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at March 31, 2009 and December 31, 2008, with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in a decrease in the net liability position of $5.1 million at March 31, 2009 and a decrease in the net liability position of $7.6 million at December 31, 2008. A 10 percent decrease in energy market prices would result in an increase in the net liability position of $5.0 million at March 31, 2009 and an increase in the net liability position of $7.6 million at December 31, 2008.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at March 31, 2009 and December 31, 2008, with all other variables (including interest rates) held constant. A 10 percent strengthening of the hedged currencies versus our functional currencies would result in an increase of the net liability position of $15.1 and $10.9 million at March 31, 2009, and December 31, 2008, respectively. A 10 percent weakening of the hedged currencies versus our functional currencies would result in a decrease of the net liability position of $15.1 and $11.8 million at March 31, 2009, and December 31, 2008, respectively. As a result, the net liability positions at March 31, 2009 would become a net asset position.

### Interest Rate Risk

We use various strategies to manage our interest rate exposure, including entering into interest rate swap agreements. As of March 31, 2009 and December 31, 2008, we had no agreements in place.

Our debt portfolio, at March 31, 2009, is composed of 31 percent fixed-rate debt and 69 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Domestic and European Credit Agreements, variable-rate industrial and pollution control revenue bonds, and foreign bank borrowings. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate instruments in our debt portfolio at March 31, 2009, a one percentage point increase or decrease in interest rates then in effect would have increased or decreased interest expense for the first three months of the year by $4.6 million.

## Market risk

As filed, 205 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,507 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal controls over financial reporting that occurred during the quarter ended March 31, 2009 that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

#### Report of Independent Registered Public Accounting Firm

The Board of Directors

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of March 31, 2009, and the related condensed consolidated statements of income for the three-month periods ended March 31, 2009 and 2008 and the condensed consolidated statements of cash flows for the three-month periods ended March 31, 2009 and 2008. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2008, and the related consolidated statements of income, changes in stockholders’ equity and cash flows for the year then ended (not presented herein) and in our report dated February 23, 2009, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2008, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

### /s/ KPMG LLP

Philadelphia, Pennsylvania

May 8, 2009

42

Filed May 8, 2009.
Source: SEC EDGAR, the filing index for accession 0001193125-09-104841. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
